95 related articles for article (PubMed ID: 2243960)
1. Complementary roles of PET and MR spectroscopy in the management of brain tumors.
Alavi A; Alavi JB; Lenkinski RE
Radiology; 1990 Dec; 177(3):617-8. PubMed ID: 2243960
[No Abstract] [Full Text] [Related]
2. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda.
Wahl RL; Hawkins RA; Larson SM; Hendee WR; Coleman RE; Holden RW; Frick MP; Gatsonis C; Brown GS; Shtern F
Radiology; 1994 Dec; 193(3):604-6. PubMed ID: 7972793
[No Abstract] [Full Text] [Related]
4. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
5. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
Alavi A; Smith R; Duncan D
J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
[No Abstract] [Full Text] [Related]
6. PET, MRI, and epilepsy.
Arroyo S; Lesser RP
Neurology; 1993 Oct; 43(10):2156. PubMed ID: 8280264
[No Abstract] [Full Text] [Related]
7. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
Bolo NR; Brennan KM; Jones RM; Budinger TF
Ann N Y Acad Sci; 1987; 508():451-9. PubMed ID: 3501936
[No Abstract] [Full Text] [Related]
8. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
Schmidt KC; Lucignani G; Sokoloff L
J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
[No Abstract] [Full Text] [Related]
9. Inflammatory bowel disease activity measured by positron-emission tomography.
Bicik I; Bauerfeind P; Breitbach T; von Schulthess GK; Fried M
Lancet; 1997 Jul; 350(9073):262. PubMed ID: 9242806
[No Abstract] [Full Text] [Related]
10. Clarification of a fractional uptake concept.
Thie JA
J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
[No Abstract] [Full Text] [Related]
11. Simplified calculation of MRglc using PET.
Phillips RL; London ED
J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
[No Abstract] [Full Text] [Related]
12. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
Anderson JH; Strandberg JD; Wong DF; Conti PS; Barker PB; Blackband SJ; Hilton J; Natarajan TK; Dannals RF; Samphilipo MA
Invest Radiol; 1994 Jun; 29(6):597-605. PubMed ID: 8088967
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis: link between PET and proton MR spectroscopic studies of the brain.
Lear JL
Radiology; 1990 Feb; 174(2):328-30. PubMed ID: 2153309
[No Abstract] [Full Text] [Related]
14. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
Tamminga CA
Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
[No Abstract] [Full Text] [Related]
15. PET quantitation: blessing and curse.
Di Chiro G; Brooks RA
J Nucl Med; 1988 Sep; 29(9):1603-4. PubMed ID: 3261788
[No Abstract] [Full Text] [Related]
16. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.
Alavi A; Kramer E; Wegener W; Alavi J
J Nucl Med; 1990 Mar; 31(3):360-4. PubMed ID: 2155315
[No Abstract] [Full Text] [Related]
17. Clinical application of PET for the evaluation of brain tumors.
Coleman RE; Hoffman JM; Hanson MW; Sostman HD; Schold SC
J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
[TBL] [Abstract][Full Text] [Related]
18. PET cancer evaluations with FDG.
Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
[No Abstract] [Full Text] [Related]
19. PET with fluorine-18 deoxyglucose for pancreatic disease.
Klever P; Bares R; Fass J; Büll U; Schumpelick V
Lancet; 1992 Nov; 340(8828):1158-9. PubMed ID: 1359226
[No Abstract] [Full Text] [Related]
20. [Functional brain study by radionuclide neuroimaging].
Uemura K
No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
